TrialLancet (London, England)2013

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Axel Grothey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.